Chemo Experts, the easiest way to learn about cancer treatment+ChemoExperts Affiliate

Treatment Name: Fosaprepitant (Emend®)

Fosaprepitant (Emend®) is a Supportive Care Therapy to prevent Nausea and Vomiting

How does fosaprepitant (Emend®) work?

Fosaprepitant is designed to block receptors in your brain that can cause nausea and vomiting called substance P/neurokinin 1 (NK1) receptors.

Chemotherapy can cause a molecule called substance P to be released, which bind to NK1 receptors in the brain and trigger nausea and vomiting. Fosaprepitant binds to NK1 receptors instead of substance P, and thereby stops the reflex to vomit.

What are the fosaprepitant (Emend®) goals of therapy?

Fosaprepitant is given to prevent both early and delayed nausea and vomiting from chemotherapy and is commonly given on a scheduled basis just before chemotherapy. Fosaprepitant is not usually used to treat nausea and vomiting. When a medicine is given to prevent nausea and vomiting, it is known as prophylaxis, or prophylactic therapy.

Schedule

Create your own Treatment Tracker

How is fosaprepitant (Emend®) therapy given to prevent nausea and vomiting?

Fosaprepitant is usually given in an outpatient infusion center, approximately 30 minutes before chemotherapy to prevent nausea and vomiting.

  • Fosaprepitant 150 mg intravenous (I.V) infusion over 20 to 30 minutes on Day 1 of chemotherapy

Fosaprepitant is typically given, along with other anti-nausea medications, for chemotherapy regimens that have a high risk of nausea and vomiting and regimens that may cause delayed nausea and vomiting. Duration of therapy depends upon response, tolerability, and number of cycles chemotherapy prescribed.

On occasion, Emend oral capsules may be dispensed by a retail pharmacy. Your Doctor will decide the best way to give Emend based upon the chemo regimen you are receiving.

Side Effects

What are the most common side effects from fosaprepitant?

In the prescribing label information (fosaprepitant package insert), the most commonly reported side effects from fosaprepitant (Emend®) are shown here:

Note: The exact percentages of patients that will experience fosaprepitant side effects is unknown because it has been used under widely varying patient populations in a variety of clinical trials.

Fosaprepitant should be used in pregnant women only if the potential benefits to the mother outweigh the potential risks to the unborn baby.

Watch videos on common fosaprepitant therapy side effects below

Side effect videos Side Effect Videos
Fatigue Fatigue DiarrheaDiarrheaAnemiaAnemiaPainPain

Monitoring

How often is fosaprepitant (Emend) monitoring needed?

Labs (blood tests) typically do not need to be monitored for fosaprepitant, but may be checked before each chemotherapy treatment.

How often is imaging needed?

Imaging is not usually necessary to start or continue fosaprepitant therapy.

How might Emend blood test results/imaging affect treatment?

Depending upon the results, your doctor may advise to continue fosaprepitant as planned or switch to an alternative therapy.

Questions to Ask Your...

A better understanding of your treatments will allow you to ask more questions of your healthcare team. We then hope that with the answers, you will get better results and have greater satisfaction with your care. Because we know it's not always easy to know what questions to ask, we've tried to make it easy for you!

Choose any healthcare provider below to see common questions that you may want to ask of this person. Then, either print each list to bring to your clinic visits, or copy the questions and send them as a message to your healthcare team through your electronic medical record.

ChemoExperts Tips

What are the most important things to know about fosaprepitant (Emend®) while receiving therapy?

  • If you are receiving warfarin, fosaprepitant may cause a decrease in your INR and your dose of warfarin may need to be adjusted
  • Fosaprepitant may decrease efficacy of oral contraceptives. Use an alternative method of contraception during treatment and for one month following the last dose of fosaprepitant
  • May interact with certain antifungal and seizure medications. Ask your doctor or pharmacist to review your medications for any possible interactions
  • Avoid therapy with St. Johns Wort as it will decrease blood levels of fosaprepitant. This could decrease the effectiveness of fosaprepitant
  • A pharmacist should ALWAYS review your medication list to ensure that drug interactions are prevented or managed appropriately

Patient Assistance & Co-payment Coverage

Created: April 1, 2020 Updated: April 17, 2020

What is Nausea and Vomiting?

 

What is nausea and vomiting?

Nausea is the uneasy feeling in the stomach that suggests that you may need to throw up. People often describe it as feeling “sick to the stomach” or “queasy.” Vomiting is when the stomach forcefully pushes its contents up and out through the mouth. A person can have nausea without vomiting, vomiting without much warning, or both.


What does nausea and vomiting look like?

Nausea may cause a person to look pale, sweaty, uncomfortable, or less interested in food. They may have a bad taste in their mouth, or certain smells may make them feel worse. Vomiting may happen once or repeatedly. Some people also have gagging, retching, stomach cramps, dizziness, or trouble keeping food and drinks down. If vomiting continues, the body can lose too much fluid, and the person can become dehydrated.


Who gets nausea and vomiting?

Anyone getting chemotherapy can have nausea or vomiting, but the chance is not the same for every treatment. Cancer treatments are grouped into different risk levels for nausea, which means how likely a drug or treatment regimen is to cause vomiting if no anti-nausea medicine is given. In general, high-risk chemotherapy causes vomiting in more than 90% of patients without prevention, moderate-risk causes it in 30% to 90%, low-risk in 10% to 30%, and minimal-risk in less than 10%. The risk level helps the care team choose how strong the prevention plan should be.

A person’s own body can also affect risk. Some people are simply more likely to feel sick from treatment than others. Prior problems with nausea, motion sickness, pregnancy-related nausea, or poor nausea control during an earlier chemotherapy cycle can all increase the risk of experiencing nausea/vomiting during treatment.


How do you prevent nausea and vomiting?

The main goal is to prevent nausea and vomiting because once symptoms begin, they can be harder to control. The timing of prevention also matters. Nausea risk can mainly be in the first 24 hours after chemotherapy, while some therapies can potentially cause nausea up to 5 days after treatment. This is why some anti-nausea medicines are given right before chemotherapy, while others may be continued for a few more days at home.
The medicines used most often belong to a few main groups: 

  • 5-HT3 blockers
    • Ondansetron (Zofran®)
    • Palonosetron (Aloxi®)
    • Dolasetron (Anzemet®)
    • Granisetron (Sancuso®, Kytril®)
  • Dexamethasone (Decadron®) 
  • NK1 blockers 
    • Aprepitant (Emend®, Cinvanti®, Aponvie®)
    • Fosaprepitant (Emend®, Focinvez®)
    • Rolapitant (Varubi®)
    • Netupitant (Akynzeo®)
    • Fosnetupitant (Akynzeo®)
  • Olanzapine (Zyprexa®)

For high-risk chemotherapy, prevention usually consists of a 3 or 4-drug plan. This often includes a combination of a 5-HT3 blocker, dexamethasone, NK1 blocker, and/or olanzapine. For moderate-risk chemotherapy, prevention is usually a 2-drug plan for many regimens; however, some patients may need a 3-drug regimen. For low-risk chemotherapy, patients often receive just one medicine before treatment, such as dexamethasone or ondansetron. For minimal-risk chemotherapy, routine prevention medicine is often not needed, though rescue medicine may still be available if symptoms happen.

How is nausea and vomiting treated?

Even with good prevention, some patients still develop nausea or vomiting. When that happens, doctors often use a breakthrough treatment plan. “Breakthrough” means symptoms happen even though preventive medicine was already given. Commonly used medications for breakthrough symptoms include:

  • Olanzapine (Zyprexa®)
  • Cannabinoids
    • Dronabinol (Marinol®)
  • Dopamine blockers
    • Haloperidol (Haldol®)
    • Metoclopramide (Reglan®)
    • Prochlorperazine (Compazine®)
  • Histamine blockers
    • Promethazine (Phenergan®)
    • Scopolamine
  • 5-HT3 blockers
    • Ondansetron (Zofran®)
    • Dolasetron (Anzemet®)
    • Granisetron (Sancuso®, Kytril®)
  • Dexamethasone (Decadron®)
  • Lorazepam (Ativan®)

If nausea and vomiting keep happening over repeated cycles, the treatment plan may be changed for the next chemotherapy cycle. For example, the team may add olanzapine, add an NK1 blocker, switch the 5-HT3 blocker, or extend how long medicine is continued after treatment.

NOTE: Treatment Options listed below are not all-inclusive. Other treatments may be available. ChemoExperts provides drug information and does not recommend any one treatment over another. Only your Doctor can choose which therapy is appropriate for you.